Spencer S. Lee, executive vice president of Chemed Corp, sold 1,000 shares on November 11, 2026, for $547,610. Shares sold at prices ranging from $547.13 to $547.81. Lee retains 12,931 shares following the transaction.
Chemed stock trades near its 52-week high of $562.24, up 29% year-to-date. The company has a market value of $7.13 billion and trades at a P/E ratio of 26.21.
Chemed reported third-quarter 2026 earnings that beat Wall Street expectations. Adjusted diluted earnings per share came in at $6.75, exceeding the forecast of $6.44 by 4.8%. Revenue reached $690.9 million, above the expected $685.04 million. Growth at the VITAS hospice unit and steady revenue gains at Roto-Rooter drove the results. The company has maintained dividend payments for 56 consecutive years.
Investors watching CHE should monitor whether the stock sustains its move near the 52-week high and how the earnings beat influences near-term price action.